Li, K., Yao, L., Chen, L., Cao, Z., Yu, S., Kuang, X., . . . Shao, Z. (2014). ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expression. Dove Medical Press.

Li, Kai, Ling Yao, Li Chen, Zhi-Gang Cao, San-Jian Yu, Xia-Ying Kuang, Xin Hu, and Zhi-Ming Shao. ID2 Predicts Poor Prognosis in Breast Cancer, Especially in Triple-negative Breast Cancer, and Inhibits E-cadherin Expression. Dove Medical Press, 2014.

Li, Kai, et al. ID2 Predicts Poor Prognosis in Breast Cancer, Especially in Triple-negative Breast Cancer, and Inhibits E-cadherin Expression. Dove Medical Press, 2014.